Lexicon Pharmaceuticals
LXRX
#7493
Rank
$0.42 B
Marketcap
$1.16
Share price
-19.44%
Change (1 day)
39.76%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$0.04 M-99.67%
2025$12.43 M-38.43%
2024$20.19 M111.04%
2023$9.57 M315.88%
2022$2.3 M-91.22%
2021$26.2 M1.63%
2020$25.78 M21.18%
2019$21.27 M-6.95%
2018$22.86 M-27.5%
2017$31.53 M18.35%
2016$26.64 M59.83%
2015$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
$8.2 M$70.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$5.36 M$19.75 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$4.5 M$68.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$3.69 M$9.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$2.08 M$10.07 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$4.76 M$11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/A$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$8.34 M$13.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/A$1.49 M๐Ÿ‡บ๐Ÿ‡ธ USA